Friday, November 16, 2012 4:09:25 PM
1. Market potential : top of the charts for any oncology treatment
2. Blockbuster potential (can't help repeat )
3. Relatively safer & easy pathway for FDA approval due to SPA/505(b) etc
4. China - First to submit with no reference approval required
5. HCC cases: 750k worldwide growing 5% every year. By 2020, it will be #1 cancer surpassing lung cancer
Lastly, MT, mentioned dose dependent PFS increase as much by a factor of 6 !
I bet the conference attendees must be excited as h*ll
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM